gene_symbol
IL5RA
hgnc_id
HGNC:6017
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Benralizumab binds IL-5Ralpha on eosinophils/basophils and, via its afucosylated Fc, engages Fc-gamma RIIIa on NK cells to trigger ADCC, depleting IL-5Ralpha+ cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06024707
disease_id_num_tar_ref
4780
drug_id_num_tar_ref
12912